Press releases and news

2021-06-30 07:00 Regulatory
Uppsala, 30 June 2021. Senzime AB (publ) announces that the company’s shares are admitted for trading on Nasdaq Stockholm's main market today. “It’s fantastic milestone for Senzime to be listed on Nasdaq Stockholm's main market. Senzime...

2021-06-24 11:05 Regulatory
Uppsala, 24 June 2021. On 23 June 2021, Senzime AB (publ) announced that Nasdaq Stockholm’s Listing Committee had approved that the company’s shares are admitted to trading on Nasdaq Stockholm’s main market, conditioned upon customary...

2021-06-23 15:30 Regulatory
Uppsala, 23 June 2021. Senzime AB (publ) announces that Nasdaq Stockholm's Listing Committee has approved the company’s application for admission of trading of the company’s shares on Nasdaq Stockholm’s main market. The approval is conditioned...

2021-06-17 12:15
News: Uppsala, on 17 June 2021. Senzimes distributor comments on the field development following the new guidelines. In recent communications information on the new launch of the AAGBI guidelines were referenced. These guidelines state that in the UK...

2021-05-22 20:30
News: Uppsala, on 22 May 2021. Senzime today announces that the Association of Anaesthetists in the UK and Ireland has issued new standards for neuromuscular monitoring stating that Quantitative neuromuscular monitoring is essential and should be available...

2021-05-11 14:25 Regulatory
The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 11 May 2021 by postal voting whereby the shareholders primarily resolved on the following matters. Annual report and results The annual...

2021-05-06 08:45 Regulatory Interim
Press release: Uppsala, May 6, 2021. Senzime AB’s (publ) Interim Report for January-March 2021 is now available on the company’s website www.senzime.com. Financial information January – March Despite the fact that Covid-19 continued...

2021-04-20 08:51
To take advantage of the opportunities the need for adequate anesthesia monitoring entails, Senzime is now expanding its commercial capacity in the US market through further recruitment of its own sales staff and by entering into distribution agreement...

2021-04-19 08:54 Regulatory Annual
For further information, please contact: Pia Renaudin, CEO of Senzime AB Tel: +46 (0)70-813 34 17, email: pia.renaudin@senzime.com Erik Bergman, CFO Tel: +46 (0)73-258 81 59, e-post: erik.bergman@senzime.com TO THE EDITORS About Senzime Senzime develops...

2021-04-12 11:54 Regulatory
Notice etc. Shareholders who wish to participate at the annual general meeting must: register with the Company no later than Monday 10 May 2021 by submitting a postal voting form in accordance with the instructions below to be received by the Company...